At G.S.K, we believe that prevention is the best medicine. Prevention is pioneering new medicines to reduce

HIV transmission, applying decades of experience and asthma control to limit long-term lung damage or stopping chronic

conditions from progressing to more serious complications because preventing

disease is the best possible outcome for all of us and is why G.S.K. unite science, technology and talent to get ahead of

disease together. Visit gsk.com to learn more.

Behind the Knife, the Surgery Podcast, where we take a behind the scenes intimate look at surgery

from leaders in the field. Welcome to another episode of BTK. It's day number two here at the

ACP GBI here in beautiful Dublin, Ireland.

Shre we've had a wonderful time so far and actually wonderful weather.

Yeah, the weather today is great and we're going to be kicking off this morning with an excellent lecture that's named BDRF lecture that's going to be given by Dr. R. R. O'Connell is actually the

vice president of R.C.S.I. here and he's going to be delivering a great

lecture on papers that have changed

collateral practice.

Ronan has done a fantastic job.

He's been on multiple editorial boards and really has a command of the literature

talking about some of the most important papers.

After that, we got a very good session on advanced malignancy talking about some upcoming trials that have really changed some practice parameters to include the prodigy 7 about

CITO reductive surgery versus HyperAC surgery for pelvic recurrence by Dr.

Ian Jenkins and kind of just talking a little bit about a panel about what we do with these complex patients.

Yeah we're going to be hopefully have some snapshot interviews coming with

Dr. Nicola Fernhead, Ian Jenkins, who will be discussing pelvic recurrence, and Dr.

Royal Hompas, who's going to be discussing some pelvic surgery emergency, a topic that's definitely

...